OPTICLONE CD3/CD4 MONOCLONAL ANTIBODIES— 510(k) K950626

Name: FDA 510(k) clearance K950626
Creator: U.S. Food and Drug Administration
Published: 1995-05-05

Substantially Equivalent

Immunotech Corp.

FDA 510(k) clearance K950626 for OPTICLONE CD3/CD4 MONOCLONAL ANTIBODIES, Substantially Equivalent on 1995-05-05. Applicant: Immunotech Corp.. Device class: 2.

Clearance details

Applicant: Immunotech Corp.
Product code: Code GKZ
Device class: Class 2
Regulation: 21 CFR 864.5220
Advisory panel: Hematology
Date received: 1995-02-10
Decision date: 1995-05-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westbrook, ME, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GKZ

view all

K253212 — XR-Series (XR-10, XR-20) Automated Hematology Analyzers2026-05-27
K243348 — Athelas Home2026-02-06
K251249 — Tru Hematology Test2026-01-16
K250943 — Sysmex XR-Series (XR-10) Automated Hematology Analyzer2025-06-25
K251371 — Sysmex XR-Series (XR-20) Automated Hematology Analyzer2025-06-25

More clearances from Immunotech Corp.

view all

K954188 — OPTICLONE IGG1 FITC/IGG2A PE ISOTYPIC CONTROL1995-11-03
K952789 — OPTICLONE CD4FITC/CD8 PE MONOCLONAL ANTIBODIES1995-08-14
K931228 — PROGESTERONE RADIOIMMUNOASSAY KIT1993-10-22
K911634 — MICROZYME(TM) FREE T4 ENZYME IMMUNOASSAY TEST1991-06-24
K911153 — MICROZYME PHENCYCLIDINE ENZYME IMMUNOASSAY TEST KT1991-06-18

Adverse events under product code GKZ

product code GKZ

Malfunction: 1,205
Total: 1,205

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.